New regulator discovered for information transfer in the brain

Neuron with synaptic contacts.<br>(Image: Biozentrum) <br>

Synapses are the most important sites of information transfer between neurons. The functioning of our brain is based on the ability of the synapses to release neurotransmitter substances in a fraction of a second, so that neuronal signals can be rapidly propagated and integrated.

Peter Scheiffele’s team has now identified a new mechanism, which ensures that synaptic vesicles, the carrier of the transmitter substances, are concentrated at their designated place, thereby contributing to rapid signal transmission.

mSYD1 as organizer of synaptic structures
The speed and precision of synaptic transmission is based on a highly complex protein apparatus in the synapse. A concentration of synaptic vesicles is found at the synaptic contact sites between neurons. When a nerve cell is activated, vesicles fuse with the edge of the synapse, the so-called active zone, and send neurotransmitters to the neighboring cells.

Peter Scheiffele’s research group has now identified a previously unknown protein called mSYD1, which regulates the deposition of the vesicles at the active zone. In nerve cells, in which no mSYD1 protein is present, synaptic contacts continue to be formed but the accumulation of the synaptic vesicles at the active zone is disrupted. This results in a significant reduction of synaptic transmission.

Inactive mSYD1 in autistic disorders
These findings provide important new insights into the mechanisms underlying the formation of functional neuronal networks. In patients with a developmental disorder belonging the autism spectrum, mSYD1 is one of a group of genes that are inactivated. In further investigations, the research group is now looking at how the inactivation of mSYD1 affects the behavior of mice, in order to gain insights into the fundamental neuronal defects associated with autism.

Original Citation
Corinna Wentzel, Julia Sommer, Ramya Nair, Adeline Stiefvater, Jean-Baptiste Sibarita, and Peter Scheiffele (2013)
mSYD1A, a Mammalian Synapse-Defective-1 Protein, Regulates Synaptogenic Signaling and Vesicle Docking.
Neuron; Published online June 19, 2013.

Further Information
Prof. Dr. Peter Scheiffele, Biozentrum, University of Basel, phone: +41 61 267 21 94, Email: peter.scheiffele@unibas.ch

Media Contact

Christoph Dieffenbacher Universität Basel

More Information:

http://www.unibas.ch

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

Cancer predisposition syndromes in children and adolescents.

Decoding Cancer: 40 Years of Breakthroughs in Genetic Research

Cancer in children and adolescents is rare. Nevertheless, malignant diseases are still one of the most common causes of death in this age group. Survivors of childhood or adolescent cancer…

Brain structure differences in adolescents at risk of early substance initiation

Let’s Think Before the First Drink: How Early Substance Use Might Lead to Brain Structure Differences Among Adolescents

Many differences appeared to exist prior to any substance use, pointing to the role brain structure may play in substance use risk, NIH-supported study suggests. Studies reveal factors that expose…

Innovative immunotherapy strategies for improving kidney cancer detection and treatment.

Combating Kidney Cancer Using Enhanced Immunotherapies

Medical University of South Carolina Hollings Cancer Center researcher receives Department of Defense Early Career Scholar Award to improve immune therapies by targeting resistant kidney tumors. A Medical University of…